TA Associates tables 280p-per-share offer for UK wound-care group Advanced Medical Solutions, valuing the AIM-listed target at over £600 million
Advanced Medical Solutions Group (AIM: AMSU), the Winsford-based developer of wound-care dressing technologies, has confirmed it is in formal negotiations with US private equity firm TA Associates over a potential all-cash takeover. Sky News first reported the approach over the weekend, citing an indicative offer price of 280 pence per share, which would value the company at more than £600 million (approximately $809 million at current exchange rates). Under the UK Takeover Code (the rulebook governing public takeovers of UK-listed companies), TA Associates has until 16 May 2026 to either announce a firm intention to make an offer or publicly withdraw — the so-called 'put up or shut up' deadline imposed by the Takeover Panel. TA Associates is no stranger to the UK market. The firm acquired British data and analytics group FD Technologies last year in a transaction valued at $722 million, demonstrating a consistent appetite for UK-listed mid-cap targets with defensible technology or IP positions. AMS has previously attracted private equity interest, including reported approaches from Bridgepoint, reflecting the sector's attractiveness to buyout capital: recurring revenues from NHS and hospital supply chains, proprietary wound-closure and haemostatic technologies, and a resilient demand profile that is largely insulated from economic cycles. The company grew from a £3 million operation to a FTSE-qualifying candidate over two decades. No financial advisers have been named by either party at this stage. The deal, if completed, would represent a take-private of an AIM-listed healthcare business — a structure that triggers specific procedural requirements under the Takeover Code and the AIM Rules.
Sign up to read →